Gene · 7372
Papers1,811
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,811
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cadmium acute exposure induces metabolic and transcriptomic perturbations in human mature adipocytes. | Toxicology | 2022 | 35301059 | PubTator, text mining | PubMed |
| A promising strategy against SARS-CoV-2: pyrimidine inhibitors synergize with nucleoside analogues. | Signal Transduct Target Ther | 2022 | 35292618 | PubTator, text mining | PubMed |
| A Continuous Assay Set to Screen and Characterize Novel Protein N-Acetyltransferases Unveils Rice General Control Non-repressible 5-Related N-Acetyltransferase2 Activity. | Front Plant Sci | 2022 | 35273627 | PubTator, text mining | PubMed |
| Pharmacogenomics Testing in Phase I Oncology Clinical Trials: Constructive Criticism Is Warranted. | Cancers (Basel) | 2022 | 35267440 | PubTator, text mining | PubMed |
| Histone deacetylase inhibitors inhibit cervical cancer growth through Parkin acetylation-mediated mitophagy. | Acta Pharm Sin B | 2022 | 35256949 | PubTator, text mining | PubMed |
| A novel circular RNA confers trastuzumab resistance in human epidermal growth factor receptor 2-positive breast cancer through regulating ferroptosis. | Environ Toxicol | 2022 | 35234341 | PubTator, text mining | PubMed |
| A Three-mRNA Signature Associated with Pyrimidine Metabolism for Prognosis of BRCA. | Biomed Res Int | 2022 | 35224098 | PubTator, text mining | PubMed |
| Pharmacogenetics of Drugs Used in the Treatment of Cancers. | Genes (Basel) | 2022 | 35205356 | PubTator, text mining | PubMed |
| Re-Discovery of Pyrimidine Salvage as Target in Cancer Therapy. | Cells | 2022 | 35203388 | PubTator, text mining | PubMed |
| UBE2T-mediated Akt ubiquitination and Akt/β-catenin activation promotes hepatocellular carcinoma development by increasing pyrimidine metabolism. | Cell Death Dis | 2022 | 35169125 | PubTator, text mining | PubMed |
| Regulation of Nucleolar Activity by MYC. | Cells | 2022 | 35159381 | PubTator, text mining | PubMed |
| RNA sequencing on muscle biopsy from a 5-week bed rest study reveals the effect of exercise and potential interactions with dorsal root ganglion neurons. | Physiol Rep | 2022 | 35133080 | PubTator, text mining | PubMed |
| Pyrimidine inhibitors synergize with nucleoside analogues to block SARS-CoV-2. | Nature | 2022 | 35130559 | PubTator, text mining | PubMed |
| The bisphenol A metabolite MBP causes proteome alterations in male Cyprinodon variegatus fish characteristic of estrogenic endocrine disruption. | Environ Pollut | 2022 | 35124124 | PubTator, text mining | PubMed |
| Duodenal Mucosal Expression of COVID-19-Related Genes in Health, Diabetic Gastroenteropathy, and Functional Dyspepsia. | J Clin Endocrinol Metab | 2022 | 35090021 | PubTator, text mining | PubMed |
| Thymidine phosphorylase induction by ionizing radiation antagonizes 5-fluorouracil resistance in human ductal pancreatic adenocarcinoma. | Radiat Environ Biophys | 2022 | 35084511 | PubTator, text mining | PubMed |
| Nucleotide biosynthesis links glutathione metabolism to ferroptosis sensitivity. | Life Sci Alliance | 2022 | 35074928 | PubTator, text mining | PubMed |
| Metabolic adjustments of blood-stage Plasmodium falciparum in response to sublethal pyrazoleamide exposure. | Sci Rep | 2022 | 35064153 | PubTator, text mining | PubMed |
| Metabolome Genome-Wide Association Study Identifies 74 Novel Genomic Regions Influencing Plasma Metabolites Levels. | Metabolites | 2022 | 35050183 | PubTator, text mining | PubMed |
| Secondary Metabolites from Marine-Derived Fungi and Actinobacteria as Potential Sources of Novel Colorectal Cancer Drugs. | Mar Drugs | 2022 | 35049922 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7372/papers?page=10